These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18241281)

  • 1. Comparison of tuberculin skin test and interferon-gamma assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-alpha therapy.
    Balato N; Ayala F; Gaudiello F; Monfrecola G; Cimmino G; Ponticiello A; Bocchino M; Matarese A; Sanduzzi A
    Br J Dermatol; 2008 Apr; 158(4):847-9. PubMed ID: 18241281
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease.
    Nakamura S; Hashimoto Y; Igawa S; Kajino M; Nishi K; Takahashi H; Mizumoto T; Iizuka H
    Clin Exp Dermatol; 2009 Dec; 34(8):e1023-4. PubMed ID: 20055828
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy between the tuberculin skin test and the levels of serum interferon-gamma in the diagnosis of tubercular infection in contacts.
    Shalabi NM; Houssen ME
    Clin Biochem; 2009 Nov; 42(16-17):1596-601. PubMed ID: 19732759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential histological and immunohistochemical assessment of proliferation and apoptotic markers during treatment of psoriasis with antitumor necrosis factor alpha (infliximab)].
    Gómez-Mateo C; Avalos-Peralta SP; Ríos-Martín JJ; Carrizosa-Esquivel AM; González-Cámpora R; Camacho-Martínez F
    Actas Dermosifiliogr; 2009 Jun; 100(5):420-4. PubMed ID: 19558920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in the age of biologic therapy.
    Hernandez C; Cetner AS; Jordan JE; Puangsuvan SN; Robinson JK
    J Am Acad Dermatol; 2008 Sep; 59(3):363-80; quiz 382-4. PubMed ID: 18694676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
    Desai N; Raste Y; Cooke NT; Harland CC
    Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
    [No Abstract]   [Full Text] [Related]  

  • 12. Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers.
    O'Neal S; Hedberg K; Markum A; Schafer S
    Int J Tuberc Lung Dis; 2009 May; 13(5):662-4. PubMed ID: 19383203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
    Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
    J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
    [No Abstract]   [Full Text] [Related]  

  • 14. Indeterminate results on the interferon-gamma release assay for tuberculosis screening should not be ignored.
    Oon HH; Chong WS; Liew CF
    Br J Dermatol; 2008 Sep; 159(4):992-3. PubMed ID: 18717676
    [No Abstract]   [Full Text] [Related]  

  • 15. Kobner phenomenon in psoriasis induced by Mantoux test.
    Piaserico S; Dan G; Peserico A
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1103-5. PubMed ID: 19175481
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests.
    Demkow U; Broniarek-Samson B; Filewska M; Lewandowska K; Maciejewski J; Zycinska K; Zwolska Z; Kus J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():209-17. PubMed ID: 19218645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM; Flogerzi B; Fallegger S; Schaffer T; Mueller S; Nicod L; Seibold F
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased toxicity of tumor necrosis factor/gamma interferon in patients with leukocytosis.
    Fiedler W; Götz G; Weh HJ; Hossfeld DK
    J Clin Oncol; 1988 Nov; 6(11):1787-8. PubMed ID: 3141593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.